The Graduate Department of Pharmaceutical Sciences offers exciting seminars featuring scientists from across Canada and around the world, with occasional seminars by our own faculty and members of other departments at U of T and surrounding hospitals/institutes. These seminars provide an opportunity for all to meet outstanding, world-renowned scientists. Seminar speakers also schedule additional time for informal discussions with faculty and students. Regular attendance at seminars is required of all graduate students.
Innovations in Pharmaceutical Sciences Seminar Series Requirement
All graduate students are required to attend the departmental seminars each year:
- Full-time students: a minimum of eight (8) departmental seminars per academic year
- Part-time/Flex-time students: a minimum of four (4) departmental seminars per academic year.
Students may fulfill up to 50% of their annual quota at sanctioned external seminars.
2024-2025 Innovations in Pharmaceutical Sciences Seminar Schedule
| Seminar Type | Date & Time | Speaker | Host | Title | LOCATION |
|---|---|---|---|---|---|
| PhD Public Seminar Series | Wednesday, September 25, 2024, 9:00am | Vishal Sangha, PhD Candidate | Dr. Reina Bendayan | Novel Approaches for Effective Folate Delivery in Cerebral Folate Deficiency Disorders | PB-850 |
|
PhD Public Seminar Series |
Wednesday, September 25, 2024, 10:00am | Fule Jackie Liu, PhD Candidate | Dr. Shirley Wu | Development and Translation of Novel Glucose-Responsive Peptide Hormone Delivery Systems for Diabetes Treatments | PB-450 |
| Innovations in Pharmaceutical Sciences Seminar Series | Monday, September 30, 2024, 11:00am | Dr. Helen Palma (Federal University of Santa Catarina, Brazil) and Lucero Diaz Gomez (University of Toronto, Public Health and Global Health). | Dr. Jillian Kohler | Challenges surrounding vaccine accessibility and adherence among the Awajún indigenous population in the Peruvian Amazon | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Tuesday, October 15, 2024, 1:00pm |
Dr. Jason Guertin (Laval University) | Dr. Mina Tadrous | Confounding and ICERs: An often ignored relationship | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, October 18, 2024, 11:00am | Professor Kazuhiko Nakatani (Osaka University) | Dr. Tigran Chalikian | Possibilities and Challenges of Small Molecule Organic Compounds for the Treatment of Repeat Diseases | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, November 1, 2024, 11:00am | Mark DiBiase (UN Development Programme) | Dr. Jillian Kohler | Advancing anti-corruption, transparency and accountability in health programmes: UNDP's approach to corruption risk management | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, November 15, 2024, 11:00am | Dr. Pedro Brugarolas | Dr. Lakshmi Kotra | Development and evaluation of PET tracers for K+ channels to image demyelinating diseases | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, November 29, 2024, 11:00am | Dr. Jack Antel (McGill University) | Dr. Lakshmi Kotra | Basis of Tissue injury and Potential for Repair in Multiple Sclerosis | PB-850 |
| PhD Public Seminar Series | Tuesday, December 3, 2024, 2:00pm | Constantine Georgiou, PhD Candidate | Dr. Ray Reilly | Radiolabeled Gold Nanoparticles for the Treatment of Glioblastoma by Convection Enhanced Delivery | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Wednesday, December 4, 2024, 10:00am | Dr. Michael Zalutsky (Duke University) | Dr. Ray Reilly | Astatine-211 – The Kinder, Gentler Alpha Emitter for Targeted Radionuclide Therapy | Zoom |
| Innovations in Pharmaceutical Sciences Seminar Series | Tuesday, December 10, 2024, 2:00pm | Dr. Laurent Salphati (Genentech) | Dr. Carolyn Cummins | Drug Metabolism and Pharmacokinetics in drug development - From uncovering unusual PK profiles to supporting drug approval | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, January 31, 2025 | Dr. Peter Roy (University of Toronto) | Dr. Carolyn Cummins | Yeast-Expressed P450s Reveal Novel Candidate Pro-Insecticides to Combat Mosquito Vectors of Malaria, West Nile, and Other Diseases | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, February 28, 2025, 11:00am | Dr. Yoon Yeo (Purdue University) | Dr. Tim Corson | Drug-eluting polymer systems for the control of local inflammation and ocular neovascularization | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, March 7, 2025, 11:00am | Dr. Scott Parnell (UNC-Chapel Hill) | Dr. Peter Wells | Genetic factors underlying susceptibility to prenatal alcohol exposure | Zoom |
| PhD Public Seminar Series | Tuesday, March 11, 2025 1:00pm |
Ashley Cheng, PhD Candidate | Dr. Peter Wells | Investigating Oxidatively Damaged DNA in the Fetal Brain: Epigenetic Implications for Neurodevelopmental Disorders | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Tuesday, March 11, 2025 2:00pm |
Dr. Frank Wuest (University of Alberta) | Dr. Ray Reilly | Imaging biomarkers in oncology: The role of radiopharmaceuticals in the era of precision oncology | PB-450 |
| PhD Public Seminar Series | Wednesday, March 12, 2025, 11:00am | Misaki Kondo, PhD Candidate | Dr. Ray Reilly | HER2-targeted Theranostic Radioimmunoconjugates for SPECT Imaging and α-particle Radioimmunotherapy of HER2-positive Breast Cancer | PB-850 |
| PhD Public Seminar Series | Tuesday, March 25, 2025, 12:00pm | Maham Zain, PhD Candidate | Dr. Rob Bonin | Chronic Pain Mediated Changes in the Sensory and Affective Coding of Low Threshold Sensory Information | PB-850 |
| PhD Public Seminar Series | Monday, March 31, 2025, 1:00pm | Chukwunonso Nwabufo, PhD Candidate | Dr. Lisa Dolovich | Impact of SARS-CoV-2 Infection on Drug Processing and Therapeutic Outcomes | PB-450 |
| PhD Public Seminar Series | Thursday, April 3, 2025, 2:00pm | Michael Saikali, PhD Candidate | Dr. Carolyn Cummins | The Development of a Targeted Parallel Reaction Monitoring Assay to Quantify all 49 Murine Nuclear Receptors and its Application in Mouse Liver | PB-1210 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, April 4, 2025 | Dr. David Moore (UC Berkeley) | Dr. Carolyn Cummins | TBA | PB-850 |
| PhD Public Seminar Series | Monday, April 7, 2025, 10:00am | Bassem Toeama, PhD Candidate | Dr. Manny Papadimitropoulos & Paul Grootendorst | Cost and Clinical Effectiveness of High-Intensity Focused Ultrasound versus Open Radical Prostatectomy, Robot-Assisted Radical Prostatectomy, or External Beam Radiation Therapy in Men with Localized Low and Intermediate Risk Prostate Cancer: A Cost-Utility Analysis | PB-450 |
| Innovations in Pharmaceutical Sciences Seminar Series | Thursday, April 10, 2025 | Dr. Hagar Labouta | PB-850 | ||
| PhD Public Seminar Series | Monday, April 14, 2025 | Tiffany Ho, PhD Candidate | Dr. Gang Zheng | Potentiation of Porphysome Photodynamic Therapy via an Unconventional Membrane Fluidization Strategy | PB-450 |
| PhD Public Seminar Series | Wednesday, April 16, 2025, 1:00pm | Chang (Shirley) Huang, PhD Candidate | Dr. Reina Bendayan | Investigating the Toxicity and Associated Mechanisms of Antiretroviral Drugs in the Central Nervous System |
PB-450 |
| PhD Public Seminar Series | Monday, May 12, 2025, 1:00pm | De Hua (Andy) Yang, PhD Candidate | Dr. Stephane Angers | Leveraging FZD Receptor Antibodies to Understand and Precisely Activate Wnt/β-Catenin Signalling Pathway for Neural Patterning in hPSC | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | Friday, June 13, 2025, 11:00am | Dr. Sara Allin |
Dr. Jen Lake |
Why is major change in Canada's health system so rare? Insights from a health policy researcher | PB-850 |
| Innovations in Pharmaceutical Sciences Seminar Series | MONDAY, July 14, 2025 | Dr. Naoki Sugimoto | Dr. Tigran Chalikian |
All about “To B or not to B” in Nucleic Acids Chemistry |
PB-255 |
Seminar Coordinator
Booking Information
Graduate Program Assistant
Email: phm.grad@utoronto.ca
Telephone: (416) 978-8896